CLS just delivered the print that justified the short retreat — a 9.5% single-day surge after Q2 results, with bears already having cleared the decks before the news hit.
The earnings reaction is the story. The stock jumped 14.4% on the day of the Q2 release, confirming what the pre-earnings positioning had implied: short sellers who spent the prior month covering aggressively — cutting positions by more than 20% over 30 days — avoided a painful squeeze. Short interest now sits at just 0.81% of free float, roughly 933,000 shares, a level that is essentially a rounding error relative to the company's institutional ownership base. The borrow market remains about as relaxed as it gets: availability runs at effectively unlimited levels, with over 113 million shares available to lend. Cost to borrow ticked up 30% on the week to 0.47%, but that is a move from near-zero to still near-zero — no signal of any supply stress. The ORTEX short score, at 26.6, has drifted marginally higher over the past two weeks but remains well below any threshold that would register as bearish conviction.
What makes the week's setup notable is the contrast between CLS and its closest peers. COHR fell 10.3% on the day and is down 23% on the week. dropped 4.5% on the day and 14.7% on the week. slipped 2.7% on the day and 5% on the week. was the worst of the group, down 12% on the day and nearly 18% on the week. Against that backdrop, Celestica's near-10% single-day gain on earnings day is not just an isolated move — it reads as a sector rotation signal, with capital actively moving toward the name best exposed to hyperscale data centre demand while rotating away from peers with less differentiated exposure.
The bull case, as laid out before the quarter, was about execution in Advanced Technology Solutions, and the results apparently delivered on that thesis. Valuation has re-rated accordingly: the P/E multiple has compressed to roughly 23.8x, down from above 27x a month ago, as earnings growth has outpaced the price rally — a relatively healthy dynamic. EV/EBITDA has also declined over the past month to 16x. The ORTEX factor scores reinforce the quality angle: EPS momentum ranks in the 72nd percentile on a 30-day basis and 73rd on 90-day, and the short score rank registers at the 93rd percentile — meaning relatively few stocks in the universe carry less short pressure than CLS right now. FMR (Fidelity) remains the largest disclosed holder at 6.1% of shares, and Franklin Resources added 365,000 shares as recently as July 1, suggesting at least some of the smart money was adding into the pre-earnings pullback.
The insider picture is worth a quick note. CEO Rob Mionis sold approximately 7,970 shares in mid-June at prices around CAD 380–388, generating roughly CAD 3.1 million in proceeds. Those sales now look well-timed relative to the pre-earnings weakness but poorly timed relative to where the stock sits today at CAD 492. The net 90-day insider position is a modest positive — 59,000 shares net bought across all insiders — largely reflecting award-related activity, not a directional signal.
The next question is whether the print sustains the divergence from peers or whether sector headwinds eventually reassert themselves — particularly if hyperscale capex commentary turns cautious in the coming weeks.
See the live data behind this article on ORTEX.
Open CLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
